PI3-kinase p85- alpha抗体, gamma抗体;GRB 1; GRB1; p85 alpha; p85; P85A_HUMAN; Phosphatidylinositol 3 kinase associated p 85 alpha; Phosphatidylinositol 3 kinase regulatory 1; Phosphatidylinositol 3 kinase regulatory subunit alpha; Phosphatidylinositol 3 kinase regulatory subunit polypeptide 1 (p85 alpha); Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphoinositide 3 kinase regulatory subunit 1 (alpha); Phosphoinositide 3 kinase regulatory subunit 1 (p85 alpha); Phosphoinositide 3 kinase regulatory subunit 1; Phosphoinositide 3 kinase regulatory subunit polypeptide 1 (p85 alpha); PI3 kinase p85 subunit alpha; PI3-kinase regulatory subunit alpha; PI3-kinase subunit p85-alpha; PI3K; PI3K regulatory subunit alpha; Pik3r1; PtdIns 3 kinase p85 alpha; PtdIns-3-kinase regulatory subunit alpha; PtdIns-3-kinase regulatory subunit p85-alpha,PhosphoPI3K p85α(Y607)
| 货号-规格 | 货期 | 价格 | 数量 |
|---|---|---|---|
| abs130868-50ug | 缺货 | ¥ 1500 .00 | |
| abs130868-100ug | 缺货 | ¥ 2300 .00 |
订购信息:
您可以从我们的授权经销商处购买absin产品或获得技术支持。若要查看您所在地区的经销商,请从以下的下拉列表中选择。
研究领域
文献相关图
Levels of Hippo signaling in peripheral tissues among CONT, CD and Non-CD groups. (A) MST1, LATS1 and YAP (one-way ANOVA) in heart. (B) MST1, LATS1, p-YAP/YAP ratio and YAP (one-way ANOVA) in liver. (C) MST1, LATS1, p-YAP/YAP ratio, YAP (one-way ANOVA) in kidney. (D) MST1, LATS1, p-YAP/YAP ratio, YAP (one-way ANOVA) in muscle. (E) MST1, LATS1, p-YAP/YAP ratio, YAP (one-way ANOVA) in gut.Data are shown as mean ± S.E.M. (n = 6). *P < 0.05, **P < 0.01 or ***P < 0.001. ANOVA: analysis of variance; CONT: control; CD: cognitive dysfunction; LATS1: large tumor suppressors 1; MST1: mammalian sterile 20-like protein kinases1; N.S.: not significant; p-YAP: phosphorylation of YAP; YAP: Yes-associated protein.
来源于《OncoTargets and Therapy》
Levels of Hippo signaling in peripheral tissues among CONT, CD and Non-CD groups. (A) MST1, LATS1 and YAP (one-way ANOVA) in heart. (B) MST1, LATS1, p-YAP/YAP ratio and YAP (one-way ANOVA) in liver. (C) MST1, LATS1, p-YAP/YAP ratio, YAP (one-way ANOVA) in kidney. (D) MST1, LATS1, p-YAP/YAP ratio, YAP (one-way ANOVA) in muscle. (E) MST1, LATS1, p-YAP/YAP ratio, YAP (one-way ANOVA) in gut.Data are shown as mean ± S.E.M. (n = 6). *P < 0.05, **P < 0.01 or ***P < 0.001. ANOVA: analysis of variance; CONT: control; CD: cognitive dysfunction; LATS1: large tumor suppressors 1; MST1: mammalian sterile 20-like protein kinases1; N.S.: not significant; p-YAP: phosphorylation of YAP; YAP: Yes-associated protein.
来源于《OncoTargets and Therapy》
温馨提示:本产品仅作科研实验使用



















